Lantern Pharma, a NASDAQ-listed company specializing in AI-driven cancer drug discovery and development, has announced a milestone with its artificial intelligence platform …
A new five-year commercial agreement and go-to-market collaboration aims to merge 1910 Genetics' comprehensive computational and biological data with Microsoft’s HPC …
British Patient Capital has invested £10m in Southampton-based biotechnology firm Curve Therapeutics through its Future Fund: Breakthrough programme and co-investment …
Exscientia plc, a UK-based AI-driven precision medicine company, has initiated a clinical study, EXCYTE-2, focusing on acute myeloid leukaemia (AML) patients. …
Neuralink, the neurotechnology firm led by entrepreneur Elon Musk, has reportedly achieved a significant milestone by successfully implanting its first …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
